Finance

Lists
ALKEM:NSE
Alkem Laboratories Ltd
5 265,00 ₹
+0,30%
(+15,50) 1D
9 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
5 252,00 ₹
High
5 299,00 ₹
Low
5 225,00 ₹
Mkt. cap
629,51 մլրդ
Avg. vol.
156,63 հզր
Volume
96,07 հզր
Dividend
1,01%
Quarterly dividend
13,25 ₹
Ex-dividend date
07 օգս, 2026 թ.
P/E ratio
29,18
52-wk high
5 933,50 ₹
52-wk low
5 051,00 ₹
EPS
180,45 ₹
Shares outstanding
119,55 մլն
No. of employees
19 հզր
Open
5 252,00 ₹
High
5 299,00 ₹
Low
5 225,00 ₹
Mkt. cap
629,51 մլրդ
Avg. vol.
156,63 հզր
Volume
96,07 հզր
Dividend
1,01%
Quarterly dividend
13,25 ₹
Ex-dividend date
07 օգս, 2026 թ.
P/E ratio
29,18
52-wk high
5 933,50 ₹
52-wk low
5 051,00 ₹
EPS
180,45 ₹
Shares outstanding
119,55 մլն
No. of employees
19 հզր
News stories
From web sources and news partners
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19,3 հզր
Founded1973
HeadquartersՄումբաի, Մահարաշտրա, Հնդկաստան
Sector-
Last report
14 օգս, 2026 թ.
Fiscal period
Q1 2027
43,49 ₹ / 47,04 ₹
-7,56%miss
Revenue / Est. (INR)
37,40 մլրդ / 37,96 մլրդ
-1,46%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
40,01 մլրդ
37,37 մլրդ
36,03 մլրդ
37,40 մլրդ
Cost of goods sold
14,01 մլրդ
12,73 մլրդ
14,33 մլրդ
12,01 մլրդ
Cost of revenue
14,01 մլրդ
12,73 մլրդ
14,33 մլրդ
12,01 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,10 մլրդ
7,22 մլրդ
17,12 մլրդ
8,09 մլրդ
Operating expense
17,73 մլրդ
17,31 մլրդ
17,80 մլրդ
18,73 մլրդ
Total operating expenses
31,74 մլրդ
30,04 մլրդ
32,13 մլրդ
30,74 մլրդ
Operating income
8,27 մլրդ
7,33 մլրդ
3,90 մլրդ
6,66 մլրդ
Other non operating income
1,04 մլրդ
1,43 մլրդ
-3,55 մլրդ
1,53 մլրդ
EBT including unusual items
8,95 մլրդ
7,81 մլրդ
4,22 մլրդ
7,71 մլրդ
EBT excluding unusual items
8,95 մլրդ
8,33 մլրդ
4,77 մլրդ
7,71 մլրդ
Income tax expense
1,16 մլրդ
1,28 մլրդ
1,71 մլրդ
2,50 մլրդ
Effective tax rate
12,98%
16,35%
40,53%
32,47%
Other operating expenses
9,69 մլրդ
9,15 մլրդ
-378,70 մլն
9,64 մլրդ
Net income
7,65 մլրդ
6,36 մլրդ
2,36 մլրդ
5,20 մլրդ
Net profit margin
19,12%
17,02%
6,56%
13,90%
Earnings per share
63,99
56,88
26,50
43,49
Interest and investment income
-
-
3,92 մլրդ
-
Interest expense
-350,20 մլն
-421,00 մլն
-336,50 մլն
-466,20 մլն
Net interest expenses
-350,20 մլն
-421,00 մլն
3,58 մլրդ
-466,20 մլն
Depreciation and amortization charges
936,10 մլն
950,10 մլն
1,06 մլրդ
1,00 մլրդ
EBITDA
9,18 մլրդ
8,11 մլրդ
4,67 մլրդ
7,43 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps